Eyelid Diseases
Conditions
Keywords
Meibomian Gland Dysfunction
Brief summary
Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized. This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21. Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
Interventions
DEVICEBlephasteam
Eye lid warming goggles
Sponsors
Laboratoires Thea
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
4 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Signed and dated informed consent. * Male or female up to 4 years old. * Known and treated symptomatic Meibomian Gland Diseases, and/or Dry Eye related to MGDs stable since at least a month. * Without any active pathology requiring a change in ocular treatments within the last month before inclusion. * Best corrected far visual acuity (VA) \> 1/10
Countries
France
Outcome results
None listed